Work

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

Year: 2013
Type: article
Abstract: A signal of cardiovascular harm with rosiglitazone led to a new FDA policy on diabetes-drug approval. As that signal has faded in recent analyses, should FDA policy change?
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2329117883
FWCI: 15.74
Cites: 6
Cited by: 207
Related to: 10